Evidence map›Paper›PMID 31668581›Full record

ArticleJournal of stroke and cerebrovascular diseases : the official journal of National Stroke Association2019

Incidence of Convexal Subarachnoid Hemorrhage in the Elderly: The Mayo Clinic Study of Aging.

Micah Yost, Catherine Arnold Fiebelkorn, Alejandro A Rabinstein, James Klaas, Jeremiah A Aakre, Robert D Brown, Michelle M Mielke, David S Knopman, Val Lowe, Ronald C Petersen and 3 more

Open access · greenAbstract read
In one paragraph

Article in Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 2 institutions in 1 country.

Micah YostDepartment of Neurology, Mayo Clinic, Rochester, Minnesota.
Catherine Arnold FiebelkornDepartment of Neurology, Mayo Clinic, Rochester, Minnesota.
Alejandro A RabinsteinDepartment of Neurology, Mayo Clinic, Rochester, Minnesota.
James KlaasDepartment of Neurology, Mayo Clinic, Rochester, Minnesota.
Jeremiah A AakreDepartment of Radiology, Mayo Clinic, Rochester, Minnesota.
Robert D BrownDepartment of Neurology, Mayo Clinic, Rochester, Minnesota.
Michelle M MielkeDepartment of Neurology, Mayo Clinic, Rochester, Minnesota; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
David S KnopmanDepartment of Neurology, Mayo Clinic, Rochester, Minnesota.
Val LoweDepartment of Neurology, Mayo Clinic, Rochester, Minnesota.
Ronald C PetersenDepartment of Neurology, Mayo Clinic, Rochester, Minnesota.
Clifford R JackDepartment of Radiology, Mayo Clinic, Rochester, Minnesota.
Prashanthi VemuriDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Jonathan Graff-RadfordDepartment of Neurology, Mayo Clinic, Rochester, Minnesota. Electronic address: Graff-Radford.Jonathan@mayo.edu.
Mayo Clinic · USMayo Clinic in Florida · US

Funding

SUPPLEMENT TO ALZHEIMERS DISEASE PATIENT REGISTRYU01AG006786 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN, JACK, CLIFFORD R. · 1986 to 2023
$49.6M
PREDICTING ALZHEIMERS DISEASE WITH MAGNETIC RESONANCER01AG011378 · NIA · MAYO CLINIC ROCHESTER · PI JACK, CLIFFORD R. · 1993 to 2017
$12.1M
Rochester Epidemiology ProjectR01AG034676 · NIA · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A, ST SAUVER, JENNIFER LYNN · 2010 to 2019
$9.5M
Disease pathways in the population determined by amyloid, tau, and neurodegeneration imaging biomarkersR37AG011378 · NIA · MAYO CLINIC ROCHESTER · PI CLIFFORD R. JACK · 2018 to 2026
$6.8M
Validating the New Criteria for Preclinical Alzheimer's diseaseR01AG041851 · NIA · MAYO CLINIC ROCHESTER · PI JACK, CLIFFORD R., KNOPMAN, DAVID S · 2012 to 2021
$6.3M
ROCHESTER EPIDEMIOLOGY PROJECTR01AR030582 · NIAMS · MAYO CLINIC ROCHESTER · PI ROCCA, WALTER A · 1986 to 2009
$5.1M
Development, Validation, and Application of an Imaging based CVD ScaleR01NS097495 · NINDS · MAYO CLINIC ROCHESTER · PI VEMURI, PRASHANTHI · 2016 to 2020
$2.9M
Interdisciplinary Infrastructure for Aging Research: Rochester Epidemiology ProjectR33AG058738 · NIA · MAYO CLINIC ROCHESTER · PI LEBRASSEUR, NATHAN K, OLSON, JANET E · 2020 to 2022
$2.4M
Cerebral Microbleeds in the Aging PopulationK76AG057015 · NIA · MAYO CLINIC ROCHESTER · PI GRAFF-RADFORD, JONATHAN · 2017 to 2021
$1.2M
NIAMS NIH HHS R01 AR030582NIA NIH HHS K76 AG057015NIA NIH HHS R01 AG011378NIA NIH HHS R01 AG034676NIA NIH HHS R01 AG041851NIA NIH HHS R33 AG058738NIA NIH HHS R37 AG011378NIA NIH HHS U01 AG006786NINDS NIH HHS R01 NS097495
6 · The paper itself

Abstract

objectivesNontraumatic convexal subarachnoid hemorrhages in the elderly can be a manifestation of cerebral amyloid angiopathy associated with a high risk of future intracerebral hemorrhage. The incidence in the elderly population is unknown. Our objectives were to: 1) determine the incidence of convexal subarachnoid hemorrhage in a population-based study, and, 2) to compare apopolipoprotein-E genotype and amyloid positron emission tomographic (PET) imaging for those with versus without hemorrhage.

methodsBetween 11/29/2004 and 3/11/2017, 4462 individuals without hemorrhage at baseline participated in the population-based Mayo Clinic Study of Aging. We used the Rochester Epidemiology Project medical records-linkage system to identify intracerebral hemorrhages. Records and images were reviewed to identify convexal subarachnoid hemorrhage. Neuroimaging characteristics, demographics, medications, and apopolipoprotein-E genotype were recorded.

resultsFour cases were identified. The incidence of convexal subarachnoid hemorrhage was 14.1 per 100,000 person years. Three occurred in women, median age, 79 (range: 71-84). One patient had coexisting cerebral microbleeds. Two participants developed a subsequent lobar intracerebral hemorrhage at a median of 4.75 years after convexal subarachnoid hemorrhage. The apopolipoprotein-E -allele combinations of the 4 were: 3/3, 3/3, 2/2, and 2/3. On Pittsburgh Compound B-PET imaging, median standardized uptake value ratio with convexal subarachnoid hemorrhage was 1.86 (range: 1.38-2.34).

conclusionsConvexal subarachnoid hemorrhage is rare in the older population, occurring with an incidence of about 14 per 100,000 person years. Yet, when present, it may be associated with a high risk of future intracerebral hemorrhage.

Indexed as

AgingAgedAged, 80 and overAge FactorsApolipoproteins ECerebral Amyloid AngiopathyFemaleGene FrequencyGenetic Predisposition to DiseaseHumansIncidenceMaleMinnesotaPositron-Emission TomographyRetrospective StudiesRisk AssessmentApoE protein, humanApolipoproteins Eamyloid PiB PETapopolipoprotein-E (APOE) e2cerebral amyloid angiopathyConvexal subarachnoid hemorrhageconvexity subarachnoid hemorrhage

Identifiers

PMID31668581
PMCPMC6886710
OpenAlexW2982168739

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.